Therefore, it is tempting to speculate that by interfering with protein interactions involved in EBOV or MV infections, as well as in IFN and pro-inflammatory cytokine induction, compounds 13 and 36 behave as antiviral agents while controlling the inflammatory response often associated with these viral infections. The gene discussed is IFNA1; the disease is viral infectious disease.